LGALS3 and glomerular disorder: Inhibition of Gal-3 seems to downregulate its reduction leading to acceleration of glomerulopathy, whereas it may play a protective role when its expression is extending in tubule and in mesangial cells during glomerulopathy, leading to a specific Gal-3-associated immune cells infiltration reduction.